Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by PBaelishhon Feb 26, 2024 11:22am
49 Views
Post# 35899153

RE:My reason to buy CZO!

RE:My reason to buy CZO!CZO is still a HUGE gamble...

This is the first time Gagnon has mentioned anything about sales VOLUME and therefore, we have zero - 0 - context.  It is more than fair to question the motive of Gagnon to shift to volumes on a 1-off basis.  20t could be big from a revenue perspective or, as is most likely the case, it is small and not as big as recent avergage quarter, or even the previous quarter.

Dum-dum doesn't realize that the disclosure of volume actually raises way more questions than anytihng else.

20t could even be the minimum order volume for the quarter... or god forbid, the year!

This 20t disclosure looks intended to baffle with BS rather than dazzle with brilliance.

Now consider some facts:
- Gagnon has not released sales volume in the past
- Gagnon has NEVER offered guidance on a quarter's performance from within the quarter(!)
- Gagnon has NEVER offered guidance... period
- Gagnon offered guidance on Q1-2024 while he has not even offered a whiff of guidance on how Q4-2023 ended up
- We have no idea (yeah, right!) of how much revenue is derived from 20t
- We are pretty much done Q1... so this IS the order from Symrise for Q1!
...but we don't know how big the order actually is.

<< Previous
Bullboard Posts
Next >>